179 related articles for article (PubMed ID: 35131872)
1. PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.
Ghilardi C; Moreira-Barbosa C; Brunelli L; Ostano P; Panini N; Lupi M; Anastasia A; Fiordaliso F; Salio M; Formenti L; Russo M; Arrigoni E; Chiaradonna F; Chiorino G; Draetta G; Marszalek JR; Vellano CP; Pastorelli R; Bani M; Decio A; Giavazzi R
Cancer Res; 2022 Apr; 82(7):1423-1434. PubMed ID: 35131872
[TBL] [Abstract][Full Text] [Related]
2. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
[TBL] [Abstract][Full Text] [Related]
3. PGC1α Promotes Cisplatin Resistance in Ovarian Cancer by Regulating the HSP70/HK2/VDAC1 Signaling Pathway.
Li Y; Kang J; Fu J; Luo H; Liu Y; Li Y; Sun L
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802591
[TBL] [Abstract][Full Text] [Related]
4. Inducing respiratory complex I impairment elicits an increase in PGC1α in ovarian cancer.
De Luise M; Sollazzo M; Lama E; Coadă CA; Bressi L; Iorio M; Cavina B; D'Angelo L; Milioni S; Marchio L; Miglietta S; Coluccelli S; Tedesco G; Ghelli A; Lemma S; Perrone AM; Kurelac I; Iommarini L; Porcelli AM; Gasparre G
Sci Rep; 2022 May; 12(1):8020. PubMed ID: 35577908
[TBL] [Abstract][Full Text] [Related]
5. SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer.
Vellinga TT; Borovski T; de Boer VC; Fatrai S; van Schelven S; Trumpi K; Verheem A; Snoeren N; Emmink BL; Koster J; Rinkes IH; Kranenburg O
Clin Cancer Res; 2015 Jun; 21(12):2870-9. PubMed ID: 25779952
[TBL] [Abstract][Full Text] [Related]
6. PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers.
Gentric G; Kieffer Y; Mieulet V; Goundiam O; Bonneau C; Nemati F; Hurbain I; Raposo G; Popova T; Stern MH; Lallemand-Breitenbach V; Müller S; Cañeque T; Rodriguez R; Vincent-Salomon A; de Thé H; Rossignol R; Mechta-Grigoriou F
Cell Metab; 2019 Jan; 29(1):156-173.e10. PubMed ID: 30244973
[TBL] [Abstract][Full Text] [Related]
7. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
[TBL] [Abstract][Full Text] [Related]
8. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
[TBL] [Abstract][Full Text] [Related]
9. MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma.
Zhang Y; Nguyen TTT; Shang E; Mela A; Humala N; Mahajan A; Zhao J; Shu C; Torrini C; Sanchez-Quintero MJ; Kleiner G; Bianchetti E; Westhoff MA; Quinzii CM; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
Cancer Res; 2020 Jan; 80(1):30-43. PubMed ID: 31694905
[TBL] [Abstract][Full Text] [Related]
10. PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions.
Nimmakayala RK; Rauth S; Chirravuri Venkata R; Marimuthu S; Nallasamy P; Vengoji R; Lele SM; Rachagani S; Mallya K; Malafa MP; Ponnusamy MP; Batra SK
Clin Cancer Res; 2021 Oct; 27(19):5415-5429. PubMed ID: 34172498
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the transcriptional coactivator PGC1α in skeletal muscles is associated with reduced expression of genes related to oxidative muscle function.
Hatazawa Y; Minami K; Yoshimura R; Onishi T; Manio MC; Inoue K; Sawada N; Suzuki O; Miura S; Kamei Y
Biochem Biophys Res Commun; 2016 Dec; 481(3-4):251-258. PubMed ID: 27816452
[TBL] [Abstract][Full Text] [Related]
12. PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer.
Wang L; Yang M; Jin H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184087
[TBL] [Abstract][Full Text] [Related]
13. PGC1α promotes cisplatin resistance in human ovarian carcinoma cells through upregulation of mitochondrial biogenesis.
Shen L; Sun B; Sheng J; Yu S; Li Y; Xu H; Su J; Sun L
Int J Oncol; 2018 Jul; 53(1):404-416. PubMed ID: 29749474
[TBL] [Abstract][Full Text] [Related]
14. Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction.
Kalliora C; Kyriazis ID; Oka SI; Lieu MJ; Yue Y; Area-Gomez E; Pol CJ; Tian Y; Mizushima W; Chin A; Scerbo D; Schulze PC; Civelek M; Sadoshima J; Madesh M; Goldberg IJ; Drosatos K
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393858
[TBL] [Abstract][Full Text] [Related]
15. ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition.
Guo W; Ma J; Yang Y; Guo S; Zhang W; Zhao T; Yi X; Wang H; Wang S; Liu Y; Dai W; Chen X; Shi Q; Wang G; Gao T; Li C
Clin Cancer Res; 2020 Jun; 26(11):2725-2739. PubMed ID: 32034077
[TBL] [Abstract][Full Text] [Related]
16. ERRα Maintains Mitochondrial Oxidative Metabolism and Constitutes an Actionable Target in PGC1α-Elevated Melanomas.
Luo C; Balsa E; Thomas A; Hatting M; Jedrychowski M; Gygi SP; Widlund HR; Puigserver P
Mol Cancer Res; 2017 Oct; 15(10):1366-1375. PubMed ID: 28596418
[TBL] [Abstract][Full Text] [Related]
17. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
[TBL] [Abstract][Full Text] [Related]
18. PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.
Bhalla K; Hwang BJ; Dewi RE; Ou L; Twaddel W; Fang HB; Vafai SB; Vazquez F; Puigserver P; Boros L; Girnun GD
Cancer Res; 2011 Nov; 71(21):6888-98. PubMed ID: 21914785
[TBL] [Abstract][Full Text] [Related]
19. Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection.
Lee J; Tsogbadrakh B; Yang S; Ryu H; Kang E; Kang M; Kang HG; Ahn C; Oh KH
Biochem Biophys Res Commun; 2021 Jan; 534():1040-1046. PubMed ID: 33121684
[TBL] [Abstract][Full Text] [Related]
20. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.
Torrano V; Valcarcel-Jimenez L; Cortazar AR; Liu X; Urosevic J; Castillo-Martin M; Fernández-Ruiz S; Morciano G; Caro-Maldonado A; Guiu M; Zúñiga-García P; Graupera M; Bellmunt A; Pandya P; Lorente M; Martín-Martín N; Sutherland JD; Sanchez-Mosquera P; Bozal-Basterra L; Zabala-Letona A; Arruabarrena-Aristorena A; Berenguer A; Embade N; Ugalde-Olano A; Lacasa-Viscasillas I; Loizaga-Iriarte A; Unda-Urzaiz M; Schultz N; Aransay AM; Sanz-Moreno V; Barrio R; Velasco G; Pinton P; Cordon-Cardo C; Locasale JW; Gomis RR; Carracedo A
Nat Cell Biol; 2016 Jun; 18(6):645-656. PubMed ID: 27214280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
